Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04430829 · ClinicalTrials.gov registry record
Diagnostic Value of Weight Bearing CT for Detecting Meniscal Tears
A clinical trial, sponsored by University of Kansas Medical Center.
- Completed
- Registry status
- 70
- Enrollment target
NCT04430829: Completed study, sponsored by University of Kansas Medical Center.
NCT04430829 is a clinical trial that has completed, run by University of Kansas Medical Center. The registered enrollment target is 70 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04430829 has completed, sponsored by University of Kansas Medical Center.
- COMPLETED
- Registry status
- 70 participants
- Enrollment target
Study Summary
This observational study will compare the clinical value of weight-bearing CT arthrography (WBCTa) with that for MRI in evaluating meniscal and cartilage lesions of the knee joint. The MRI Osteoarthritis Knee Score (MOAKS) and modified MOAKS for WBCTa will be used to compare findings between MRI and WBCTa of the knee while comparing with surgical measurements using the ICRS scoring system. The study hypothesis is that meniscal and cartilage lesions may be missed by non-weight-bearing MRI, but detected by WBCTa.
Primary Outcome
Pre-operative cartilage lesion scoring of meniscal lesions on WBCTa (modified MOAKS score) and MRI (modified MOAKS score) will be compared with arthroscopic visual MOAKS scoring of meniscal lesions.
Interventions
- DIAGNOSTIC_TEST Weight-Bearing CT arthrography
- DIAGNOSTIC_TEST Knee MRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2020-06-08 |
| Est. Completion | 2023-11-14 |
What the finished NCT04430829 record still lists
NCT04430829 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 70 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Weight-Bearing CT arthrography is the first listed.
NCT04430829 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04430829 about?
NCT04430829 is a clinical study titled "Diagnostic Value of Weight Bearing CT for Detecting Meniscal Tears". This observational study will compare the clinical value of weight-bearing CT arthrography (WBCTa) with that for MRI in evaluating meniscal and cartilage lesions of the knee joint. The MRI Osteoarthritis Knee Score (MOAKS) and modified MOAKS for WBCTa will be used to compare findings between MRI and...
What is the current status of trial NCT04430829?
This trial is currently completed. The enrollment target is 70 participants. The study started on 2020-06-08. Estimated completion is 2023-11-14.
What interventions are being tested in trial NCT04430829?
The interventions under investigation include: Weight-Bearing CT arthrography (DIAGNOSTIC_TEST), Knee MRI (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04430829?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI